Back
BioCryst Pharmaceuticals Stock Predictions
Better Than Oil Stocks
CLICK HERE TO FIND OUT MORE
Sell
40
BCRX
BioCryst Pharmaceuticals
Last Price:
7.87
Seasonality Move:
8.45%
7 Day Trial
ALL ACCESS PASS
$
7
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)BioCryst Pharmaceuticals Stock Forecast
- Over the next 52 weeks, BioCryst Pharmaceuticals has on average historically risen by 57.1% based on the past 30 years of stock performance.
- BioCryst Pharmaceuticals has risen higher in 13 of those 30 years over the subsequent 52-week period, corresponding to a historical accuracy of 43.33%
-
Is BioCryst Pharmaceuticals Stock Undervalued?
The current BioCryst Pharmaceuticals [BCRX] share price is $7.93. The Score for BCRX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal. - BCRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will BioCryst Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, BioCryst Pharmaceuticals has on average historically risen by 57.1% based on the past 30 years of stock performance.
BioCryst Pharmaceuticals Stock Rating
Sell
40
BioCryst Pharmaceuticals (BCRX)
is a Sell
Is BioCryst Pharmaceuticals overpriced?
- BioCryst Pharmaceuticals has risen higher in 13 of those 30 years over the subsequent 52-week period, corresponding to a historical accuracy of 43.33%
BioCryst Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biocryst.com
52-Week Data
52-Week High:
8.88
52-Week Low:
4.03
Prediction Charts
Market Cap:
1.64B
Price in USD:
7.93
Volume:
1.77M
Beta:
1.68
Technical Analysis
SMA50:
7.60
SMA100:
7.70
SMA200:
6.67
52-Wk Change:
39.37%
Stock Predictions
-
Is BioCryst Pharmaceuticals stock public?
Yes, BioCryst Pharmaceuticals is a publicly traded company. -
What is the BioCryst Pharmaceuticals stock quote today?
The BioCryst Pharmaceuticals stock price is 7.93 USD today. -
How to buy BioCryst Pharmaceuticals stock online?
You can buy BioCryst Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-20 | 7.16 | 7.30 | 7.51 | 7.09 |
| Nov-21 | 7.30 | 7.49 | 7.51 | 7.02 |
| Nov-22 | 7.46 | 7.60 | 7.66 | 7.42 |
| Nov-25 | 7.60 | 7.27 | 7.69 | 7.24 |
| Nov-26 | 7.27 | 7.49 | 7.54 | 7.17 |
| Nov-27 | 7.54 | 7.50 | 7.63 | 7.43 |
| Nov-29 | 7.50 | 7.50 | 7.53 | 7.36 |
| Dec-2 | 7.45 | 7.38 | 7.52 | 7.21 |
| Dec-3 | 7.32 | 7.19 | 7.43 | 7.14 |
| Dec-4 | 7.20 | 7.33 | 7.56 | 7.11 |
| Dec-5 | 7.39 | 7.84 | 7.93 | 7.34 |
| Dec-6 | 7.89 | 7.61 | 8.16 | 7.60 |
| Dec-9 | 7.60 | 7.73 | 7.80 | 7.55 |
| Dec-10 | 7.75 | 7.93 | 8.00 | 7.68 |
BioCryst Pharmaceuticals Earnings
BioCryst Pharmaceuticals Earnings Report: Per Share BioCryst Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
BioCryst Pharmaceuticals Forecast Revenue Growth
BioCryst Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for BioCryst Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.67 per share, and an increase next year of $0.32 per share.
* BioCryst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.